Showing posts tagged with "small-molecules-and-synthetic-therapeutics"
Recently, the Thorn-Seshold Research Group at Ludwig Maximilian University of Munich (LMU) purchased a Biotage® Selekt flash purification system to help them with their work. Biotage caught up with tw...
First, how did you end up where you are today? “I have always been fascinated with the ability of chemistry to produce drugs, medicines and therapies. It was therefore natural for me to pursue my Ph.D...
Dr. Thomas L. Mindt and Xabier Guarrochena in the laboratory at the University of Vienna’s Institute of Inorganic Chemistry. Dr. Thomas L. Mindt, Professor of Bioinorganic Radiochemistry at the Univer...
Figure 1: Scientists at the SGC-UNC site (from left to right): Alfredo Picado, PhD; Benjamin Eduful, PhD; Sean O’Byrne, PhD.
The Gakushuin University Nakamura Group is engaged in “new drug discovery” at the interface between organic chemistry and molecular biology, developing liposomal boron nanocapsule drug delivery system...
Richard E. Johnsson, Ph.D. is Head of Peptide Chemistry at Red Glead Discovery in Lund, Sweden. Red Glead Discovery is a pre-clinical drug discovery CRO offering a broad range of services to Life Scie...
Genome Science Research Institute, Genome Science Research Department 1, Screening Group
Figure 1: PeptiDream Inc. relocated their head office in August 2017 and established its new research centre in the Kawasaki City International Strategic Centre. The expanded facility is expected to s...
The absence of impurities in peptides, synthesized via SPPS, is vital for reliable assay results. However, especially in drug discovery screenings (number of peptides > 24), potentially low-purity cru...